The project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN trial. The Assay will be available as a service in the Babraham Institute’s Flow Cytometry Facility.

A new energised Argenta brand campaign – One Brand, One Vision – emphasises the company's commitment to advancing world-class treatments and therapies for healthier and happier animals by delivering trusted, innovative ‘molecule to market’ solutions to customers.

CELLBANKER® freezing media from AMSBIO is now available in customizable formats, seamlessly integrating into cell manufacturing processes with personalized formulations, volumes, and packaging.

License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness.

HP Inc., recently announced that it has entered into a new, commercial agreement with valued strategic partner Tecan, to make the Uno Single Cell Dispenser available to life science and pharma researchers worldwide.

Innovation provides United States with first workflow update in 25 years.

AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools.

InSphero, and ATCC, will work together to introduce new paradigms in the rapidly evolving field of 3D cell-based oncology research.

Proteintech Genomics, a subsidiary of Proteintech Group, inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail.

Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit.